STARD7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.024200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.060820E-01
Normal-vs-Stage2
4.258400E-02
Normal-vs-Stage3
3.125800E-02
Normal-vs-Stage4
1.400580E-01
Stage1-vs-Stage2
9.544600E-01
Stage1-vs-Stage3
1.043960E-01
Stage1-vs-Stage4
8.613000E-01
Stage2-vs-Stage3
8.791600E-02
Stage2-vs-Stage4
8.946800E-01
Stage3-vs-Stage4
1.833190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.717700E-02
Normal-vs-AfricanAmerican
2.360800E-01
Normal-vs-Asian
6.479800E-03
Caucasian-vs-AfricanAmerican
4.104800E-01
Caucasian-vs-Asian
1.424170E-01
AfricanAmerican-vs-Asian
5.556400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.975600E-02
Normal-vs-Female
4.022100E-02
Male-vs-Female
7.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.111400E-01
Normal-vs-Age(41-60Yrs)
7.032100E-02
Normal-vs-Age(61-80Yrs)
2.560000E-02
Normal-vs-Age(81-100Yrs)
2.806400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.154400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.152000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.065600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.855700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.662200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.627000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.439400E-03
Normal-vs-Daily Drinker
2.212000E-02
Normal-vs-Weekly Drinker
1.698770E-01
Normal-vs-Occasional Drinker
3.188300E-02
Normal-vs-Social Drinker
8.564300E-02
Non Drinker-vs-Daily Drinker
4.361400E-01
Non Drinker-vs-Weekly Drinker
9.446200E-02
Non Drinker-vs-Occasional Drinker
1.216600E-01
Non Drinker-vs-Social Drinker
6.558500E-02
Daily Drinker-vs-Weekly Drinker
3.228000E-01
Daily Drinker-vs-Occasional Drinker
4.597000E-01
Daily Drinker-vs-Social Drinker
2.756800E-01
Weekly Drinker-vs-Occasional Drinker
6.803600E-01
Weekly Drinker-vs-Social Drinker
9.742800E-01
Occasional Drinker-vs-Social Drinker
6.579200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.682200E-01
Normal-vs-Grade 2
9.984800E-01
Normal-vs-Grade 3
9.739600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.323600E-01
Grade 1-vs-Grade 3
3.103400E-01
Grade 1-vs-Grade 4
9.682200E-01
Grade 2-vs-Grade 3
5.072600E-01
Grade 2-vs-Grade 4
9.984800E-01
Grade 3-vs-Grade 4
9.739600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.423700E-02
Normal-vs-NonDiabetic
1.456280E-02
Diabetic-vs-NonDiabetic
8.899600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.353800E-02
Normal-vs-NoPancreatitis
1.947660E-02
Pancreatitis-vs-NoPancreatitis
4.547600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.177800E-02
Normal-vs-N1
4.507800E-02
N0-vs-N1
5.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.715230E-01
Normal-vs-TP53-NonMutant
1.671370E-01
TP53-Mutant-vs-TP53-NonMutant
6.769000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
